Proceeds from issue of ordinary shares Proceeds from issue of ordinary shares Non-deductible expenses Tax effect of expense not deductible in determining taxable profit (tax loss) Tax effect of expense not deductible in determining taxable profit (tax loss) Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items] Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items] Disclosure of classes of share capital [line items] Disclosure of classes of share capital [line items] New standards and interpretations not yet adopted Disclosure of initial application of standards or interpretations [text block] Asset Acquisition [Axis] Asset Acquisition [Axis] Asset Acquisition United Kingdom, Pounds United Kingdom, Pounds Executive officers and consultants Executive Officers And Consultants [Member] Executive Officers And Consultants Classes of financial liabilities [axis] Classes of financial liabilities [axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Expected dividend yield Expected Dividend As Percentage, Other Equity Instruments Granted Expected Dividend As Percentage, Other Equity Instruments Granted Goodwill Goodwill [member] Disclosure of detailed information about intangible assets [line items] Disclosure of detailed information about intangible assets [line items] Shares issued during period (in shares) Number of Shares Issued as Convertible Instruments Number of Shares Issued as Convertible Instruments Expense from share-based payment transactions Expense from share-based payment transactions Levels of fair value hierarchy [axis] Levels of fair value hierarchy [axis] Number of share options granted in share-based payment arrangement Number of share options granted in share-based payment arrangement Exercisable period Share-Based Compensation Arrangement, Expiration Period Share-Based Compensation Arrangement, Expiration Period Research and development expense Research and development expense Research and development expense Reversal of share subscriptions (in shares) Reversal of share subscriptions (in shares) Number Of Shares Reversed Through Share Subscriptions, Equity Number Of Shares Reversed Through Share Subscriptions, Equity Employees Certain Employees, Two [Member] Certain Employees, Two Purchase of intangible assets Purchase of intangible assets, classified as investing activities Change in fair value of investments measured at fair value through profit or loss Adjustments For Gains (Losses) On Fair Value Adjustment, Investments Adjustments For Gains (Losses) On Fair Value Adjustment, Investments Retained earnings Deficit Retained earnings Entity's total for business combinations [member] Entity's total for business combinations [member] Option Expiration Period Twenty Four Option Expiration Period Twenty Four [Member] Option Expiration Period Twenty Four Number of Warrants Warrants, Number of Shares [Roll Forward] Warrants, Number of Shares Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] Number of other equity instruments forfeited in share-based payment arrangement Number of other equity instruments forfeited in share-based payment arrangement INVESTING ACTIVITIES Cash flows from (used in) investing activities [abstract] GENERAL AND ADMINISTRATIVE EXPENSES Disclosure of general and administrative expense [text block] Adelia Acquisition Acquisitions through business combinations, intangible assets other than goodwill Schedule of Financial Assets Disclosure of financial assets [text block] Disclosure of attribution of expenses by nature to their function [table] Disclosure of attribution of expenses by nature to their function [table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location Carrying amount [member] Carrying amount [member] Warrants to directors Warrants to Directors, Original Agreement [Member] Warrants to Directors, Original Agreement Disclosure of research and development expense [text block] Disclosure of research and development expense [text block] Other current assets Adjustments for decrease (increase) in other current assets Deferred tax assets Net deferred tax assets Deferred tax assets Vesting upon change of control transaction Vesting, Seven [Member] Vesting, Seven Rx Debentures Rx Debentures [Member] Rx Debentures Cybin IRL Limited Cybin IRL Limited [Member] Cybin IRL Limited INCOME TAX Disclosure of income tax [text block] Equipment Balance Balance Property, plant and equipment Property, plant and equipment August 3, 2023 Warrant Expiration Period One [Member] Warrant Expiration Period One Option Expiration Period Thirteen Option Expiration Period Thirteen [Member] Option Expiration Period Thirteen Summary of stock option information, exercise prices Disclosure of range of exercise prices of outstanding share options [text block] Schedule of Financial Liabilities Disclosure of financial liabilities [text block] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Vesting [Domain] Vesting [Domain] Vesting [Domain] Unobservable inputs [member] Unobservable inputs [member] INTANGIBLE ASSETS Disclosure of intangible assets [text block] Number of share options exercisable in share-based payment arrangement Number of share options exercisable in share-based payment arrangement Warrant Expiration Period [Domain] Warrant Expiration Period [Domain] Warrant Expiration Period [Domain] Accretion expense Increase (decrease) in contingent liabilities recognised in business combination Proceeds from issuance of common shares, net Proceeds from issuing shares Exercised (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement Number of other equity instruments exercised or vested in share-based payment arrangement Option Expiration Period Fourteen Option Expiration Period Fourteen [Member] Option Expiration Period Fourteen Impact of 10% change in foreign currency rate Risk exposure associated with instruments sharing characteristic COST OF GOODS SOLD Cost of sales Classes of share capital [axis] Classes of share capital [axis] Schedule of subsidiaries and functional currencies Detail Description Of Functional Currencies [Table Text Block] Detail Description Of Functional Currencies Profit or loss [abstract] Scenario [Axis] Scenario [Axis] OTHER INCOME (EXPENSES) Miscellaneous Income (Expense) [Abstract] Miscellaneous Income (Expense) Ownership [Axis] Ownership [Axis] Serenity Serenity [Member] Serenity Share price, additional value (in CAD per share) Convertible Stock, Additional Amount Issuable Convertible Stock, Additional Amount Issuable Interest income Adjustments for interest income Warrants Warrant reserve [member] Executive officers Executive Officer [Member] Subscriptions price (in CAD per share) Share Subscriptions, Price Per Share Share Subscriptions, Price Per Share Current assets Current assets Sale Of Stock [Axis] Sale Of Stock [Axis] Sale Of Stock Proceeds from current borrowings Proceeds from current borrowings Award vesting period Vesting Requirements For Share-Based Payment Arrangement, Vesting Period Vesting Requirements For Share-Based Payment Arrangement, Vesting Period Corporate Information and Statement of IFRS Compliance [Abstract] Corporate Information and Statement of IFRS Compliance [Abstract] Impairment of investment Adjustments For Impairment Loss (Reversal Of Impairment Loss) Recognized In Profit Or Loss, Investments Adjustments For Impairment Loss (Reversal Of Impairment Loss) Recognized In Profit Or Loss, Investments Entity Address, State or Province Entity Address, State or Province Cash flows used in operating activities before net changes in non-cash working capital items Cash flows from (used in) operations before changes in working capital Professional and consulting fees Professional and consulting fees Professional and consulting fees Brokers Brokers [Member] Brokers Conversion Period [Domain] Conversion Period [Domain] Conversion Period [Domain] CORPORATE INFORMATION Disclosure of notes and other explanatory information [text block] Broker Warrants Broker Warrants [Member] Broker Warrants Milestone Transaction [Axis] Milestone Transaction [Axis] Milestone Transaction Cybin Corp. Cybin Corp [Member] Cybin Corp Milestone Transaction One Milestone Transaction One [Member] Milestone Transaction One Schedule of equipment Disclosure of detailed information about property, plant and equipment [text block] Accounts receivable Trade receivables [member] Option Expiration Period Sixteen Option Expiration Period Sixteen [Member] Option Expiration Period Sixteen Subscription receipts issued (in shares) Number of Shares Issued Through Subscription Receipts, Equity Number of Shares Issued Through Subscription Receipts, Equity Number of warrants vesting monthly (in shares) Class of Warrant or Right, Number Of Warrants Vesting Monthly Class of Warrant or Right, Number Of Warrants Vesting Monthly Option Expiration Period Thirty Option Expiration Period Thirty [Member] Option Expiration Period Thirty Professional and consulting fees Professional fees expense All Currencies [Domain] All Currencies [Domain] Currency translation Description of accounting policy for foreign currency translation [text block] Total Non-Current Assets Non-current assets Loss generated in the year ended March 31, 2022 Loss Generated In The Year Ended March 31, 2022 [Member] Loss Generated In The Year Ended March 31, 2022 Operating expense Operating expense Disclosure of detailed information about intangible assets [table] Disclosure of detailed information about intangible assets [table] Reconciliation of changes in intangible assets other than goodwill [abstract] Reconciliation of changes in intangible assets other than goodwill [abstract] Increase (Decrease) Through Issuance of Warrants, Equity Increase (Decrease) Through Issuance of Warrants, Equity Increase (Decrease) Through Issuance of Warrants, Equity Weighted average fair value at measurement date, share options granted Weighted average fair value at measurement date, share options granted Document Annual Report Document Annual Report Risk-free interest rate Risk Free Interest Rate, Other Equity Instruments Granted Risk Free Interest Rate, Other Equity Instruments Granted Disclosure of reconciliation of changes in goodwill [table] Disclosure of reconciliation of changes in goodwill [table] Share Capital, Reserves, and Other Equity Interest [Abstract] Share Capital, Reserves, and Other Equity Interest [Abstract] Entity Addresses [Table] Entity Addresses [Table] Shares issued for Adelia at acquisition (in shares) Issue for acquisition (in shares) Number Of Shares Issued Through Acquisition Of Subsidiary, Equity Number Of Shares Issued Through Acquisition Of Subsidiary, Equity Geographical [Axis] Geographical [Axis] Reconciliation of changes in property, plant and equipment [abstract] Reconciliation of changes in property, plant and equipment [abstract] Financial Instruments [Abstract] Financial Instruments [Abstract] Warrant, conversion ratio Class of Warrant or Right, Convertible, Conversion Ratio Class of Warrant or Right, Convertible, Conversion Ratio Weighted average remaining of outstanding contractual life Weighted Average Remaining Contractual Life of Other Equity Instruments Weighted Average Remaining Contractual Life of Other Equity Instruments Financial assets, class [member] Financial assets, class [member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Current Current assets [abstract] Number of warrants issued (in shares) Number of Other Equity Instruments Issued in Share-Based Payment Arrangement, Accumulated Number of Other Equity Instruments Issued in Share-Based Payment Arrangement, Accumulated Aggregate fair value, vested Aggregate Fair Value, Other Equity Instruments Exercised Or Vested Aggregate Fair Value, Other Equity Instruments Exercised Or Vested Document Type Document Type Option Expiration Period Forty Option Expiration Period Forty [Member] Option Expiration Period Forty Related Party [Abstract] Related Party Disclosure [Abstract] Option Expiration Period Ten Option Expiration Period Ten [Member] Option Expiration Period Ten Other expense, by function Other expense, by function Increase (decrease) through expiration of warrants, equity Increase (decrease) through expiration of warrants, equity Increase (decrease) through expiration of warrants, equity Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] Other Equity Instruments, Trading Days, Minimum Notice Other Equity Instruments, Trading Days, Minimum Notice Other Equity Instruments, Trading Days, Minimum Notice Warrants to directors and advisors, August 20, 2020 issuance Warrants to Directors and Advisors, August 20, 2020 Issuance [Member] Warrants to Directors and Advisors, August 20, 2020 Issuance Option Expiration Period Forty Two Option Expiration Period Forty Two [Member] Option Expiration Period Forty Two Depreciation, property, plant and equipment Depreciation, property, plant and equipment Share capital Description of accounting policy for issued capital [text block] Number of options held in escrow (in shares) Number of Share Options Held In Escrow Number of Share Options Held In Escrow Cash Cash Net cash flows used in operating activities Cash flows from (used in) operating activities Cash flows from (used in) operating activities Gains (losses) on financial assets at fair value through profit or loss, mandatorily measured at fair value Gains (losses) on financial assets at fair value through profit or loss, mandatorily measured at fair value Share-based compensation Description of accounting policy for share-based payment transactions [text block] Asset acquisition, consideration transferred Asset Acquisition, Consideration Transferred Asset Acquisition, Consideration Transferred Borrowings, conversion price (in CAD per share) Borrowings, Convertible, Conversion Price Borrowings, Convertible, Conversion Price Assets [member] Assets [member] Option Expiration Period Five Option Expiration Period Five [Member] Option Expiration Period Five Reverse stock split conversion ratio Reverse Stock Split, Conversion Ratio Reverse Stock Split, Conversion Ratio Document Period End Date Document Period End Date Unit Purchase Warrants Unit Purchase Warrants [Member] Unit Purchase Warrants Disclosure of temporary difference, unused tax losses and unused tax credits [line items] Disclosure of temporary difference, unused tax losses and unused tax credits [line items] CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS Disclosure of accounting judgements and estimates [text block] Number of share options forfeited in share-based payment arrangement Number of options, forfeited (in shares) Number of share options forfeited in share-based payment arrangement CONTRACTS AND COMMITMENTS Disclosure of commitments and contingent liabilities [text block] Weighted average exercise price Warrants, Weighted Average Exercise Price [Roll Forward] Warrants, Weighted Average Exercise Price TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Equity and liabilities Deferred tax assets Deferred Tax Assets, Gross Deferred Tax Assets, Gross Common Share Purchase Warrants Common Share Purchase Warrants [Member] Common Share Purchase Warrants Copyrights, patents and other industrial property rights, service and operating rights [member] Copyrights, patents and other industrial property rights, service and operating rights [member] Option Expiration Period Forty Five Option Expiration Period Forty Five [Member] Option Expiration Period Forty Five (Increase (Decrease) Through Share Options Forfeited In Share Based Payment Award, Equity (Increase (Decrease) Through Share Options Forfeited In Share Based Payment Award, Equity (Increase (Decrease) Through Share Options Forfeited In Share Based Payment Award, Equity Financial liabilities, class [member] Financial liabilities, class [member] Useful life of intangible assets Useful life measured as period of time, intangible assets other than goodwill Outstanding (in shares) Outstanding (in shares) Number of other equity instruments outstanding in share-based payment arrangement Number of other equity instruments outstanding in share-based payment arrangement Net cash flows from financing activities Cash flows from (used in) financing activities Disclosure of significant unobservable inputs used in fair value measurement of assets [table] Disclosure of significant unobservable inputs used in fair value measurement of assets [table] Inventories Description of accounting policy for measuring inventories [text block] Shares issued for Adelia at acquisition Increase (decrease) through acquisition of subsidiary, equity Warrant Expiration Period [Axis] Warrant Expiration Period [Axis] Warrant Expiration Period Impairment of inventory Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories Share price (in CAD per share) Share Price Share Price Shares available for grant, percent of total shares outstanding (up to) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant, Percent Of Total Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant, Percent Of Total Shares Outstanding Other Other Deferred Tax Asset [Member] Other Deferred Tax Asset Useful life of equipment Useful life measured as period of time, property, plant and equipment Items of contingent liabilities [axis] Items of contingent liabilities [axis] Shares issued on contingent liability Adelia milestones Issue Of Equity, Contingent Consideration Issue Of Equity, Contingent Consideration Reasonably possible change in risk variable, impact on net loss Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Impact On Profit (Loss) Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Impact On Profit (Loss) Non-cash portion of listing fees Adjustments For Listing Fees Adjustments For Listing Fees Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Events after reporting period [Abstract] Events after reporting period [Abstract] Key management personnel compensation, short-term employee benefits Key management personnel compensation, short-term employee benefits Option Expiration Period Eight Option Expiration Period Eight [Member] Option Expiration Period Eight Entity Registrant Name Entity Registrant Name Vested upon Cybin Corp. reaching certain performance milestones Share-based Payment, Vesting, Period Five [Member] Share-based Payment, Vesting, Period Five Option Expiration Period Thirty Seven Option Expiration Period Thirty Seven [Member] Option Expiration Period Thirty Seven Option Expiration Period Thirty Five Option Expiration Period Thirty Five [Member] Option Expiration Period Thirty Five Entity Address, City or Town Entity Address, City or Town Estimated grant date fair value Weighted average fair value at measurement date, other equity instruments granted Founders' round additional capital Increase (Decrease) Through Contributed Capital, Equity Increase (Decrease) Through Contributed Capital, Equity 2041 Year 2041 [Member] Year 2041 Unrealized foreign currency translation loss Adjustments For Unrealized Gain (Loss) On Foreign Currency Translation Adjustments For Unrealized Gain (Loss) On Foreign Currency Translation November 15, 2025 Warrant Expiration Period Five [Member] Warrant Expiration Period Five Number Of Shares Issued Through Share Offering, Equity Number Of Shares Issued Through Share Offering, Equity Number Of Shares Issued Through Share Offering, Equity Other contingent liabilities [member] Other contingent liabilities [member] Goodwill Description of accounting policy for goodwill [text block] Other comprehensive income, net of tax, exchange differences on translation of foreign operations Unrealized gain on translation of foreign operations Other comprehensive income, net of tax, exchange differences on translation of foreign operations Exchangeable prior to December 14, 2022 Conversion Period One [Member] Conversion Period One Warrant, threshold trading days Other Equity Instruments, Threshold Trading Days Other Equity Instruments, Threshold Trading Days Disclosure of Financial Assets and Liabilities [Line Items] Disclosure of Financial Assets and Liabilities [Line Items] Disclosure of Financial Assets and Liabilities [Line Items] Reconciliation of changes in contingent liabilities recognised in business combination [abstract] Reconciliation of changes in contingent liabilities recognised in business combination [abstract] Inventory Adjustments for decrease (increase) in inventories Entity Emerging Growth Company Entity Emerging Growth Company Vested upon Cybin Corp. completing a public offering Share-based Payment, Vesting, Period Four [Member] Share-based Payment, Vesting, Period Four Employee stock option Employee Stock Option [Member] Employee Stock Option Contingent consideration accretion Adjustments For Expense Arising From Passage of Time, Contingent Liabilities Recognised In Business Combination Adjustments For Expense Arising From Passage of Time, Contingent Liabilities Recognised In Business Combination Auditor Name Auditor Name Annual Information Form Annual Information Form Vested quarterly over 24 months from the date of issuance Share-based Payment, Vesting, Period Two [Member] Share-based Payment, Vesting, Period Two Trading Symbol Trading Symbol Entity File Number Entity File Number 2040 Year 2040 [Member] Year 2040 Share Purchase Warrants, November 15, 2025 expiry Common Share Purchase Warrants, November 15, 2025 Expiry [Member] Common Share Purchase Warrants, November 15, 2025 Expiry Journey Journey [Member] Journey Summary of significant unobservable inputs used, equity Disclosure of significant unobservable inputs used in fair value measurement of equity [text block] SHARE CAPITAL Disclosure of share capital, reserves and other equity interest [text block] Disclosure of detailed information about property, plant and equipment [line items] Disclosure of detailed information about property, plant and equipment [line items] Foreign currency rate Closing foreign exchange rate Difference between Canadian and foreign tax rates Tax effect of foreign tax rates Tax effect of foreign tax rates Other related parties Other related parties [member] Canada CANADA Major items causing the income tax rate to differ from the Canadian statutory rate Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates [Table Text Block] Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates Title of Individual [Axis] Title of Individual [Axis] Current prepaid expenses Current prepaid expenses Option Expiration Period Twenty One Option Expiration Period Twenty One [Member] Option Expiration Period Twenty One Non-capital loss carryforwards Unused tax losses [member] Total Non-Current Liabilities Non-current liabilities Risk free interest rate, share options granted Risk free interest rate, share options granted Weighted average exercise price of share options exercisable in share-based payment arrangement Weighted average exercise price of share options exercisable in share-based payment arrangement Ownership Proportion of ownership interest in subsidiary Directors And Executive Officers Directors And Executive Officers [Member] Directors And Executive Officers Non-current Non-current assets [abstract] Weighted average exercise price of share options exercised in share-based payment arrangement Weighted average exercise price of share options exercised in share-based payment arrangement Warrant reserve Warrant reserve Computer equipment [member] Computer equipment [member] Consultant two Consultant two [Member] Consultant two Warrants Description of accounting policy for warrants [text block] Summary of warrants Disclosure of number and weighted average exercise prices of other equity instruments [text block] OTHER COMPREHENSIVE LOSS Other comprehensive income [abstract] Expense Arising From Passage of Time, Contingent Liabilities Recognised In Business Combination Expense Arising From Passage of Time, Contingent Liabilities Recognised In Business Combination Expense Arising From Passage of Time, Contingent Liabilities Recognised In Business Combination Change in cash Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Immediate Vesting Immediate Vesting [Member] Immediate Vesting Property, plant and equipment [member] Property, plant and equipment [member] Expected volatility, share options granted Expected volatility, share options granted Shares issued on conversion of debt Increase (decrease) through conversion of convertible instruments, equity Income Statement Location [Domain] Income Statement Location [Domain] Income Statement Location [Domain] Option Expiration Period Twenty Two Option Expiration Period Twenty Two [Member] Option Expiration Period Twenty Two Contingent consideration payable Non-Current Contingent Liabilities Recognised In Business Combination Non-Current Contingent Liabilities Recognised In Business Combination Option Expiration Period Two Option Expiration Period Two [Member] Option Expiration Period Two Accounting Policies [Abstract] Accounting Policies [Abstract] June 15, 2025 Warrant Expiration Period Three [Member] Warrant Expiration Period Three GOODWILL Disclosure of goodwill [text block] Office and administration Occupancy expense Equipment Description of accounting policy for property, plant and equipment [text block] Loss generated in the period from December 4, 2020 to March 31, 2021 Loss Generated In the Period From December 4, 2020 To March 31, 2021 [Member] Loss Generated In the Period From December 4, 2020 To March 31, 2021 Analysis of income and expense [abstract] Director Director [Member] Shares issued for cash - options exercise Proceeds from exercise of options Proceeds from issue of ordinary shares in private placement Proceeds From Issue of Ordinary Shares in Private Placement Proceeds From Issue of Ordinary Shares in Private Placement Disclosure of detailed information about property, plant and equipment [table] Disclosure of detailed information about property, plant and equipment [table] Ireland IRELAND Expected dividend as percentage, share options granted Expected dividend as percentage, share options granted Ownership [Domain] Ownership [Domain] Option Expiration Period Thirty Six Option Expiration Period Thirty Six [Member] Option Expiration Period Thirty Six Entity Interactive Data Current Entity Interactive Data Current Schedule of remuneration of key management personnel Disclosure of transactions between related parties [text block] Interest income Interest Income, Fair Value Measurement, Assets Interest Income, Fair Value Measurement 2042 Year 2042 [Member] Year 2042 Payroll, consulting and benefits Employee benefits expense Warrants and Rights Outstanding Warrants and Rights Outstanding Warrants and Rights Outstanding Accelerated vesting, number of shares Number of Share Options on Accelerated Vesting Schedule Number of Share Options on Accelerated Vesting Schedule Option Expiration Period Forty Four Option Expiration Period Forty Four [Member] Option Expiration Period Forty Four Shares issued for cash - warrant exercise Proceeds from exercise of warrants Proceeds from exercise of warrants Entity Primary SIC Number Entity Primary SIC Number Share-based compensation Key management personnel compensation, share-based payment Investment, Type [Axis] Investment, Type [Axis] Investment, Type Currency risk [member] Currency risk [member] Business Contact Business Contact [Member] Option Expiration Period Nine Option Expiration Period Nine [Member] Option Expiration Period Nine Loss per share Description of accounting policy for earnings per share [text block] Proceeds from issuance of warrants, net Proceeds From Issuance Of Warrants Proceeds From Issuance Of Warrants Milestone Transaction Two Milestone Transaction Two [Member] Milestone Transaction Two Consultant Consultant [Member] Consultant Disclosure of classes of share capital [table] Disclosure of classes of share capital [table] Goodwill Balance Balance Goodwill Number of other equity instruments expired in share-based payment arrangement Number of other equity instruments expired in share-based payment arrangement Underwriters’ Warrants Underwriters’ Warrants [Member] Underwriters’ Warrants Option Expiration Period Eleven Option Expiration Period Eleven [Member] Option Expiration Period Eleven Shares issued for amalgamation Increase (Decrease) Through Amalgamation, Equity Increase (Decrease) Through Amalgamation, Equity Expected recovery at statutory rate Tax expense (income) at applicable tax rate Tax expense (income) at applicable tax rate Current Contingent Liabilities Recognised In Business Combination Current Contingent Liabilities Recognised In Business Combination Current Contingent Liabilities Recognised In Business Combination Vested on the date of issuance Share-based Payment, Vesting, Period One [Member] Share-based Payment, Vesting, Period One Other current assets Other current assets Number of warrants held in escrow (in shares) Number of Warrants Held In Escrow Number of Warrants Held In Escrow Option Expiration Period One Option Expiration Period One [Member] Option Expiration Period One Phase 1, DMT Study Phase 1, DMT Study [Member] Phase 1, DMT Study Increase (Decrease) Through Share Offering, Equity Increase (Decrease) Through Share Offering, Equity Increase (Decrease) Through Share Offering, Equity Number of other equity instruments exercisable in share-based payment arrangement Number of other equity instruments exercisable in share-based payment arrangement Trade and other current receivables Trade and other current receivables Scenario [Domain] Scenario [Domain] Potential ordinary share transactions [member] Potential ordinary share transactions [member] Share issuance costs Share Issuance Costs [Member] Share Issuance Costs Other income Other income Classes of assets [axis] Classes of assets [axis] Document Fiscal Year Focus Document Fiscal Year Focus Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement Warrants exercisable (in CAD per share) Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement Exchangeable prior to December 14, 2023 Conversion Period Two [Member] Conversion Period Two Option Expiration Period Twenty Nine Option Expiration Period Twenty Nine [Member] Option Expiration Period Twenty Nine Taxation Description of accounting policy for income tax [text block] Share Capital Issued capital [member] Temporary difference, unused tax losses and unused tax credits [axis] Temporary difference, unused tax losses and unused tax credits [axis] Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement Schedule of intangible assets Disclosure of detailed information about intangible assets [text block] Warrant, stock price trigger (in CAD per share) Other Equity Instruments, Stock Price Trigger Other Equity Instruments, Stock Price Trigger Capital Management [Abstract] Capital Management [Abstract] Increase (decrease) through exercise of warrants, equity Increase (decrease) through exercise of warrants, equity Vested monthly over 18 months from the date of issuance Share-based Payment, Vesting, Period Three [Member] Share-based Payment, Vesting, Period Three Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Reconciliation of number of shares outstanding [abstract] Reconciliation of number of shares outstanding [abstract] Disclosure of nature and extent of risks arising from financial instruments [line items] Disclosure of nature and extent of risks arising from financial instruments [line items] Option Expiration Period Forty Three Option Expiration Period Forty Three [Member] Option Expiration Period Forty Three Number of options, assumed in consolidation (in shares) Number Of Share Options Assumed In Share Consolidation In Share-Based Payment Arrangement Number Of Share Options Assumed In Share Consolidation In Share-Based Payment Arrangement Adjustments for items not affecting cash: Adjustments to reconcile profit (loss) [abstract] Financial liabilities, measured at fair value: Financial Liabilities At Fair Value Through Other Comprehensive Income, Category [Member] Financial Liabilities At Fair Value Through Other Comprehensive Income, Category Option Expiration Period Thirty Four Option Expiration Period Thirty Four [Member] Option Expiration Period Thirty Four Non-current investments other than investments accounted for using equity method Non-current investments other than investments accounted for using equity method Auditor Firm ID Auditor Firm ID Milestone achieved Settled liabilities, contingent liabilities recognised in business combination Cybin US1 Cybin US [Member] Cybin US Accumulated other comprehensive income Accumulated other comprehensive income Change in unrecognized deferred tax assets Tax Effect Of Change In Deferred Tax Assets Tax Effect Of Change In Deferred Tax Assets Tax Effect Of Change In Deferred Tax Assets Statement of changes in equity [line items] Statement of changes in equity [line items] Cash and cash equivalents Description of accounting policy for determining components of cash and cash equivalents [text block] Intangible Assets [Abstract] Intangible Assets [Abstract] Local Phone Number Local Phone Number CAPITAL MANAGEMENT Disclosure of objectives, policies and processes for managing capital [text block] Option Expiration Period Six Option Expiration Period Six [Member] Option Expiration Period Six Entity's total for related parties [member] Entity's total for related parties [member] Employees and consultants Employees and Consultants [Member] Employees and Consultants Classes of property, plant and equipment [axis] Classes of property, plant and equipment [axis] Option Expiration Period Four Option Expiration Period Four [Member] Option Expiration Period Four Disclosure of Fair Value Measurement of Assets and Liabilities [Line Items] Disclosure of Fair Value Measurement of Assets and Liabilities [Line Items] Disclosure of Fair Value Measurement of Assets and Liabilities [Line Items] Business development Business Development Expense Business Development Expense TOTAL SHAREHOLDERS' EQUITY Balance Balance Equity Working capital Working Capital Working Capital Option Expiration Period Thirty Two Option Expiration Period Thirty Two [Member] Option Expiration Period Thirty Two FINANCING ACTIVITIES Cash flows from (used in) financing activities [abstract] Year 2043 Year 2043 [Member] Year 2043 Asset Acquisition [Domain] Asset Acquisition [Domain] Asset Acquisition [Domain] Number of Shares Issued Upon Conversion of Convertible Instruments Number of Shares Issued Upon Conversion of Convertible Instruments Number of Shares Issued Upon Conversion of Convertible Instruments SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION Disclosure of changes in accounting policies, accounting estimates and errors [text block] Convertible Stock, Conversion Price Convertible Stock, Conversion Price Convertible Stock, Conversion Price Significant components of deferred tax assets Disclosure of temporary difference, unused tax losses and unused tax credits [text block] Increase (decrease) through exercise of options, equity Increase (decrease) through exercise of options, equity Non-adjusting events after reporting period [member] Non-adjusting events after reporting period [member] Types of risks [axis] Types of risks [axis] Geographical [Domain] Geographical [Domain] Statement of financial position [abstract] Issuance of convertible debt Issue of convertible instruments Number of Common Shares Held In Escrow Number of Common Shares Held In Escrow Number of Common Shares Held In Escrow Address Type [Domain] Address Type [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Share Purchase Warrants, June 15, 2020 issuance Common Share Purchase Warrants, June 15, 2020 Issuance [Member] Common Share Purchase Warrants, June 15, 2020 Issuance Option Expiration Period [Domain] Option Expiration Period [Domain] Option Expiration Period [Domain] Option Expiration Period Twenty Six Option Expiration Period Twenty Six [Member] Option Expiration Period Twenty Six Types of share-based payment arrangements [axis] Types of share-based payment arrangements [axis] Shares issued for cash net of share issuance costs – private placement (in shares) Number Of Shares Issued Through Private Placement, Equity Number Of Shares Issued Through Private Placement, Equity Shares issued on contingent liability Adelia milestones Increase (Decrease) Through Contingent Consideration, Equity Increase (Decrease) Through Contingent Consideration, Equity Increase (Decrease) Through Contingent Consideration, Equity Changes in equity [abstract] Changes in equity [abstract] Comprehensive income Comprehensive income Additions Additions other than through business combinations, intangible assets other than goodwill Disclosure Of Non-Capital Losses Expiration [Table] Disclosure Of Non-Capital Losses Expiration [Table] Disclosure Of Non-Capital Losses Expiration [Table] Option Expiration Period Three Option Expiration Period Three [Member] Option Expiration Period Three Share issue related cost Share issue related cost Schedule of Quantitative Information of Significant Unobservable inputs in Fair Value Measurements Disclosure of significant unobservable inputs used in fair value measurement of liabilities [text block] Number of Shares Issued Through Contingent Consideration, Equity Number of Shares Issued Through Contingent Consideration, Equity Number of Shares Issued Through Contingent Consideration, Equity Expected payment period for contractual commitment Contractual Capital Commitments, Expected Payment Period Contractual Capital Commitments, Expected Payment Period Exercise Price of Other Equity Instruments in Share-based Payment Arrangement Exercise Price of Other Equity Instruments in Share-based Payment Arrangement Exercise Price of Other Equity Instruments in Share-based Payment Arrangement Year 2044 Year 2044 [Member] Year 2044 Licences [member] Licences [member] Option Expiration Period Forty One Option Expiration Period Forty One [Member] Option Expiration Period Forty One Option Expiration Period Twenty Five Option Expiration Period Twenty Five [Member] Option Expiration Period Twenty Five Additions other than through business combinations, property, plant and equipment Additions other than through business combinations, property, plant and equipment RELATED PARTY TRANSACTIONS AND BALANCES Disclosure of related party [text block] Option Expiration Period Eighteen Option Expiration Period Eighteen [Member] Option Expiration Period Eighteen Disclosure of non-adjusting events after reporting period [line items] Disclosure of non-adjusting events after reporting period [line items] February 4, 2024 Warrant Expiration Period Ten [Member] Warrant Expiration Period Ten Percentage of equity financing offering price Borrowings, Conversion Price, Percentage Of Equity Financing Offering Price Borrowings, Conversion Price, Percentage Of Equity Financing Offering Price Audited Annual Financial Statements Audited Annual Financial Statements Intangible assets under development [member] Intangible assets under development [member] Changes in carrying value of contingent consideration Disclosure Of Detailed Information About Business Combination Contingent Consideration [Text Block] Disclosure Of Detailed Information About Business Combination Contingent Consideration Borrowings by name [axis] Borrowings by name [axis] Contingent consideration payable Contingent Consideration Payable [Member] Contingent Consideration Payable Exercise price (in dollars per share) Exercise price of outstanding share options Share premium Share premium Disclosure of Financial Assets and Liabilities [Table] Disclosure of Financial Assets and Liabilities [Table] Disclosure of Financial Assets and Liabilities [Table] Interest income Interest income Current accrued expenses and other current liabilities Current accrued expenses and other current liabilities Option Expiration Period Twenty Eight Option Expiration Period Twenty Eight [Member] Option Expiration Period Twenty Eight Increase (Decrease) Through Conversion of Convertible Instruments, Equity, Shares Increase (Decrease) Through Conversion of Convertible Instruments, Equity, Shares Increase (Decrease) Through Conversion of Convertible Instruments, Equity, Shares Loss Carryforward Expiration [Domain] Loss Carryforward Expiration [Domain] Loss Carryforward Expiration [Domain] Weighted average exercise price, beginning balance (in dollars per share) Weighted average exercise price, ending balance (in dollars per share) Weighted average exercise price of share options outstanding in share-based payment arrangement Discount rate Discount rate, measurement input [member] Net loss and comprehensive loss before income taxes Accounting profit Impairment loss Impairment loss recognised in profit or loss, goodwill Weighted average number of ordinary shares used in calculating basic earnings per share Weighted average number of ordinary shares used in calculating basic earnings per share Exercise price (in CAD per share) Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted Valuation allowance Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Valuation Allowance Property, Plant and Equipment1 [Abstract] Property, Plant and Equipment [Abstract] Schedule of goodwill Disclosure of reconciliation of changes in goodwill [text block] Consultants Consultants [Member] Consultants Employees Certain Employees, One [Member] Certain Employees, One Amendment Flag Amendment Flag Option Expiration Period Thirty One Option Expiration Period Thirty One [Member] Option Expiration Period Thirty One Option Expiration Period Nineteen Option Expiration Period Nineteen [Member] Option Expiration Period Nineteen COMMITMENTS [Table] COMMITMENTS [Table] COMMITMENTS [Table] Cash, beginning of period Cash, end of period Cash and cash equivalents Reversal of share subscriptions Reversal of share subscriptions Increase (Decrease) Through Share Subscriptions Reversed, Equity Increase (Decrease) Through Share Subscriptions Reversed, Equity Basic earnings (loss) per share Basic earnings (loss) per share Income Taxes [Abstract] Income Taxes [Abstract] Classes of intangible assets and goodwill [axis] Classes of intangible assets and goodwill [axis] Disclosure of Monetary Assets and Liabilities Currency Risk Fluctuations Disclosure of nature and extent of risks arising from financial instruments [text block] Entity Current Reporting Status Entity Current Reporting Status Audit Information [Abstract] Audit Information [Abstract] Option Expiration Period Thirty Nine Option Expiration Period Thirty Nine [Member] Option Expiration Period Thirty Nine Contractual commitments Contractual capital commitments SUBSEQUENT EVENTS Disclosure of non-adjusting events after reporting period [text block] Disclosure of significant unobservable inputs used in fair value measurement of equity [table] Disclosure of significant unobservable inputs used in fair value measurement of equity [table] Beginning balance Ending balance Contingent liabilities recognised in business combination Non-current Non-current liabilities [abstract] Other Equity Instruments in Share-based Payment Arrangement, Term Other Equity Instruments in Share-based Payment Arrangement, Term Other Equity Instruments in Share-based Payment Arrangement, Term Accumulated other comprehensive income (loss) Accumulated other comprehensive income [member] Intangible Assets Under Development - Assumed Liabilities Intangible Assets Under Development - Assumed Liabilities [Member] Intangible Assets Under Development - Assumed Liabilities Impairment of promissory note Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, loans and advances Finders Warrants Finders Warrants [Member] Finders Warrants Basis of consolidation Disclosure of basis of consolidation [text block] August 2021 Compensation Common Share Warrant August 2021 Compensation Common Share Warrant [Member] August 2021 Compensation Common Share Warrant Level 3 of fair value hierarchy [member] Level 3 of fair value hierarchy [member] Effects of exchange rate changes on cash Effect of exchange rate changes on cash and cash equivalents Disclosure of temporary difference, unused tax losses and unused tax credits [table] Disclosure of temporary difference, unused tax losses and unused tax credits [table] Financial liabilities Financial liabilities Laboratory Equipment Laboratory Equipment [Member] Laboratory Equipment Balance (in shares) Balance (in shares) Number of shares outstanding Number of shares outstanding Statement of changes in equity [abstract] EXPENSES Expenses by nature [abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Loss Carryforward Expiration [Axis] Loss Carryforward Expiration [Axis] Loss Carryforward Expiration Agents Agents [Member] Agents 2021 Warrants 2021 Warrant [Member] 2021 Warrant Currency [Axis] Currency [Axis] Document Registration Statement Document Registration Statement Title of Individual [Domain] Title of Individual [Domain] Intangible Assets Under Development - Upfront Intangible Assets Under Development - Upfront [Member] Intangible Assets Under Development - Upfront Unobservable inputs [axis] Unobservable inputs [axis] Private placement Private Placement [Member] Private Placement Potential consulting services payment Asset Acquisition, Consulting Services, Maximum Expense Asset Acquisition, Consulting Services, Maximum Expense Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement Weighted Average Exercise Price Of Other Equity Instruments Issued In Share-based Payment Arrangement Categories of financial assets [axis] Categories of financial assets [axis] Accretion of convertible debt Accretion Of Convertible Debt Accretion Of Convertible Debt Reasonably possible change in risk variable, percent Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Percent Sensitivity Analysis For Types Of Risks, Reasonably Possible Change In Risk Variable, Percent Intangible Assets Description of accounting policy for intangible assets other than goodwill [text block] Share-based compensation Tax Effect Of Share Based Compensation Tax Effect Of Share Based Compensation Tax Effect Of Share Based Compensation Advisory service fee Services received, related party transactions Share-based compensation Adjustments for share-based payments Change in fair value of contingent consideration Increase (decrease) in contingent consideration asset (liability) Disclosure of intangible assets material to entity [text block] Disclosure of intangible assets material to entity [text block] Financial assets and liabilities Financial Assets And Liabilities Financial Assets And Liabilities Option Expiration Period Seven Option Expiration Period Seven [Member] Option Expiration Period Seven Cash Cash [Member] Cash Significant unobservable input, assets Significant unobservable input, assets Disclosure of associates [table] Disclosure of associates [table] Pre-acquisition loss generated up to December 4, 2020 Pre-Acquisition Loss Generated Up To December 4, 2020 [Member] Pre-Acquisition Loss Generated Up To December 4, 2020 Shares issued for amalgamation (in shares) Number Of Shares Issued Through Amalgamation, Equity Number Of Shares Issued Through Amalgamation, Equity Increase (decrease) through net exchange differences, intangible assets other than goodwill Increase (decrease) through net exchange differences, intangible assets other than goodwill Gross carrying amount [member] Gross carrying amount [member] Number Of Shares Issued Through Exercise Of Warrants, Equity Number Of Shares Issued Through Exercise Of Warrants, Equity Number Of Shares Issued Through Exercise Of Warrants, Equity LIABILITIES Liabilities [abstract] Goodwill [Abstract] Goodwill [Abstract] Shares issued upon conversion, percentage Convertible Stock, Shares Issued upon Conversion, Percentage Convertible Stock, Shares Issued upon Conversion, Percentage Investor relations Investor Relations Expense Investor Relations Expense Equity [member] Equity [member] Disclosure of subsidiaries [line items] Disclosure of subsidiaries [line items] Disclosure of subsidiaries [table] Disclosure of subsidiaries [table] Purchase of investment Purchase of financial instruments, classified as investing activities Capital market Capital Market Expense Capital Market Expense Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table] Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table] Class of Warrant or Right, Outstanding Class of Warrant or Right, Outstanding Class of Warrant or Right, Outstanding Current investments Current investments Number of options, beginning balance (in shares) Number of options, ending balance (in shares) Number of share options outstanding in share-based payment arrangement Number of share options outstanding in share-based payment arrangement Warrants to directors, amended Warrants to Directors, Amended Agreement [Member] Warrants to Directors, Amended Agreement Accounts receivable Adjustments for decrease (increase) in trade accounts receivable Deferred compensation Deferred compensation [Member] Deferred compensation Option Expiration Period Twenty Option Expiration Period Twenty [Member] Option Expiration Period Twenty Share Purchase Warrants Share Purchase Warrants [Member] Share Purchase Warrants Effect of foreign exchange Increase (decrease) through net exchange differences, property, plant and equipment Title of 12(b) Security Title of 12(b) Security Increase (decrease) through net exchange differences, deferred tax liability (asset) Increase (decrease) through net exchange differences, deferred tax liability (asset) Adelia Adelia [Member] Adelia Summary of share capital Disclosure of classes of share capital [text block] Accrued executive bonuses Short-term employee benefits accruals Gains (losses) on exchange differences on translation of foreign operations, before tax Gains (losses) on exchange differences on translation of foreign operations, before tax Entity Addresses [Line Items] Entity Addresses [Line Items] Conversion Period [Axis] Conversion Period [Axis] Conversion Period Computer software [member] Computer software [member] February 1, 2024 Warrant Expiration Period Two [Member] Warrant Expiration Period Two Accelerated vesting, share-based payment compensation expense Expense From Share-based Payment Transaction, Accelerated Cost Expense From Share-based Payment Transaction, Accelerated Cost Disclosure Of Non-Capital Losses Expiration [Line Items] Disclosure Of Non-Capital Losses Expiration [Line Items] Disclosure Of Non-Capital Losses Expiration [Line Items] Option Expiration Period Twelve Option Expiration Period Twelve [Member] Option Expiration Period Twelve Financial assets, category [member] Financial assets, category [member] Options Reserve of share-based payments [member] Risks [member] Risks [member] Unsecured bank loans received Unsecured bank loans received Option Expiration Period Thirty Eight Option Expiration Period Thirty Eight [Member] Option Expiration Period Thirty Eight Expected life (in years) Other Equity Instruments Life, Other Equity Instruments Granted Other Equity Instruments Life, Other Equity Instruments Granted Categories of financial liabilities [axis] Categories of financial liabilities [axis] Classes Of Financial Assets And Liabilities [Domain] Classes Of Financial Assets And Liabilities [Domain] Classes Of Financial Assets And Liabilities [Domain] All levels of fair value hierarchy [member] All levels of fair value hierarchy [member] Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Entity Address, Country Entity Address, Country Marketing media Sales and marketing expense Prepaid expenses Adjustments for decrease (increase) in prepaid expenses Number Of Share Options Cancelled In Share-Based Payment Arrangement Number Of Share Options Cancelled In Share-Based Payment Arrangement Number Of Share Options Cancelled In Share-Based Payment Arrangement Reconciliation of changes in intangible assets and goodwill [abstract] Reconciliation of changes in intangible assets and goodwill [abstract] Non-capital losses Non-Capital Loss Carryforward Non-Capital Loss Carryforward Disclosure of nature and extent of risks arising from financial instruments [table] Disclosure of nature and extent of risks arising from financial instruments [table] Weighted average remaining contractual life of outstanding share options Weighted average remaining contractual life of outstanding share options Option Expiration Period Twenty Three Option Expiration Period Twenty Three [Member] Option Expiration Period Twenty Three Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right Classes of financial assets [axis] Classes of financial assets [axis] Total Current Liabilities Current liabilities Proceeds from subscription issuance Proceeds From Issuance Of Subscriptions Proceeds From Issuance Of Subscriptions Section 382 limitation Section 382 Limitation Section 382 Limitation Accounts payable and accrued liabilities Accounts Payable And Accrued Liabilities [Member] Accounts Payable And Accrued Liabilities GROSS PROFIT Gross profit Auditor Location Auditor Location Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Warrant, threshold consecutive trading days Other Equity Instruments, Threshold Consecutive Trading Days Other Equity Instruments, Threshold Consecutive Trading Days Options Share-Based Payment Arrangement, Option [Member] Options United States UNITED STATES General and administrative costs General And Administrative Expense [Member] General And Administrative Expense Accounts payable and accrued liabilities Adjustments For Increase (Decrease) In Accrued And Other Liabilities Adjustments For Increase (Decrease) In Accrued And Other Liabilities Increase (decrease) through share-based payment transactions, equity Increase (decrease) through share-based payment transactions, equity Vesting monthly over 5 months Vesting, Six [Member] Vesting, Six Disclosure of associates [line items] Disclosure of associates [line items] Non-capital losses expiration Disclosure Of Expiration Of Non Capital Losses [Table Text Block] Disclosure Of Expiration Of Non Capital Losses Option Expiration Period Twenty Seven Option Expiration Period Twenty Seven [Member] Option Expiration Period Twenty Seven Conversion of stock, shares issued, effective price per share (in dollars per share) Convertible Stock, Shares Issued, Effective Price Per Share Convertible Stock, Shares Issued, Effective Price Per Share Business combinations [axis] Business combinations [axis] ASSETS Assets [abstract] August 20, 2025 Warrant Expiration Period Four [Member] Warrant Expiration Period Four Security Exchange Name Security Exchange Name COMMITMENTS [Line Items] COMMITMENTS [Line Items] COMMITMENTS [Line Items] Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement Licenses - 2 Licenses - 2 [Member] Licenses - 2 Critical Accounting Estimates and Judgements [Abstract] Critical Accounting Estimates and Judgements REVENUE Revenue Financial instruments Description of accounting policy for financial instruments [text block] Contributed Surplus Share premium [member] Statement of compliance Statement of IFRS compliance [text block] Loss Generation Period [Domain] Loss Generation Period [Domain] Loss Generation Period [Domain] Percentage of conversion price Warrant Reserve, Exercise Price, Percentage Of Conversion Price Warrant Reserve, Exercise Price, Percentage Of Conversion Price Shares issued for cash net of share issuance costs – private placement Increase (Decrease) Through Private Placement, Equity Increase (Decrease) Through Private Placement, Equity Schedule of General and Administrative Expenses Disclosure of attribution of expenses by nature to their function [text block] Temporary difference, unused tax losses and unused tax credits [member] Temporary difference, unused tax losses and unused tax credits [member] Statement of cash flows [abstract] Cover [Abstract] Preferred shares Preference shares [member] Class B Shares Class B Shares [Member] Class B Shares Advisors Advisors [Member] Advisors Asset Acquisition Asset Acquisition [Member] Asset Acquisition Weighted average exercise price of share options forfeited in share-based payment arrangement Weighted average exercise price of share options forfeited in share-based payment arrangement Additions (refer to note 4) Acquisitions through business combinations, intangible assets and goodwill Forecast Forecast [Member] Classes of intangible assets other than goodwill [axis] Classes of intangible assets other than goodwill [axis] Licences - 1 Licences - 1 [Member] Licences - 1 Vesting [Axis] Share-based Payment, Vesting Period [Axis] Share-based Payment, Vesting Period Number of shares held in escrow (in shares) Number of shares in entity held by entity or by its subsidiaries or associates Options exercised (in shares) Number of options, exercised (in shares) Number of share options exercised in share-based payment arrangement Number of share options exercised in share-based payment arrangement Business Combination [Abstract] Business Combination [Abstract] Business Combination [Abstract] Advancement of development programs Advancement of development programs Advancement of development programs Net cash flows used in investing activities Cash flows from (used in) investing activities Issued capital Issued capital Listing fees Listing Fees Expense Listing Fees Expense Classes Of Financial Assets And Liabilities [Axis] Classes Of Financial Assets And Liabilities [Axis] Classes Of Financial Assets And Liabilities Current Fiscal Year End Date Current Fiscal Year End Date Changes in fair value measurement, assets [abstract] Changes in fair value measurement, assets [abstract] Disclosure of contingent liabilities in business combination [table] Disclosure of contingent liabilities in business combination [table] Depreciation/CCA differences Property, Plant And Equipment Related Temporary Differences [Member] Property, Plant And Equipment Related Temporary Differences EQUIPMENT Disclosure of property, plant and equipment [text block] Amortisation expense Amortisation, intangible assets other than goodwill Components of equity [axis] Components of equity [axis] Consultants, Two Consultants, Two [Member] Consultants, Two Warrants to advisors, September 14, 2020 issuance Warrants to Advisors, September 14, 2020 Issuance [Member] Warrants to Advisors, September 14, 2020 Issuance Disclosure of fair value measurement [text block] Disclosure of fair value measurement [text block] Shares issued on conversion of debt (in shares) Number Of Shares Issued Through Conversion Of Convertible Debt, Equity Number Of Shares Issued Through Conversion Of Convertible Debt, Equity Current Current liabilities [abstract] Weighted average exercise price of share options granted in share-based payment arrangement Weighted average exercise price of share options granted in share-based payment arrangement Deficit Retained earnings [member] Commitments [Abstract] Commitments [Abstract] Contact Personnel Name Contact Personnel Name Disclosure Of Capital Structure Disclosure Of Capital Structure [Table Text Block] Disclosure Of Capital Structure CONTINGENT CONSIDERATION PAYABLE Disclosure of contingent liabilities in business combination [text block] Option Expiration Period Fifteen Option Expiration Period Fifteen [Member] Option Expiration Period Fifteen Intangible assets and goodwill [member] Intangible assets and goodwill [member] Purchase of equipment Purchase of property, plant and equipment, classified as investing activities Lab and Administration Lab and Administration Lab and Administration Research Research And Development Expense [Member] Research And Development Expense Warrants to directors, officers and advisors, June 15, 2020 issuance Warrants to Directors, Officers and Advisors, June 15, 2020 Issuance [Member] Warrants to Directors, Officers and Advisors, June 15, 2020 Issuance Functional and presentation currency Description of accounting policy for functional currency [text block] Trade and other current payables Trade and other current payables Borrowings, interest rate Borrowings, interest rate Non-adjusting events after reporting period [axis] Non-adjusting events after reporting period [axis] Change in fair value Increase (decrease) in fair value measurement, liabilities Entity Ex Transition Period Entity Ex Transition Period Disclosure of reconciliation of changes in goodwill [line items] Disclosure of reconciliation of changes in goodwill [line items] Reserve of share-based payments Reserve of share-based payments General and administrative expense Total General and administrative expense Summary of measurement of stock option fair value assumptions Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block] R&D expenditures R&D expenditures [Member] R&D expenditures Entity Address, Address Line One Entity Address, Address Line One Disclosure of significant accounting policies [text block] Disclosure of significant accounting policies [text block] Intangible assets other than goodwill [member] Intangible assets other than goodwill [member] Financial assets, measured at fair value: Financial assets at fair value through other comprehensive income, category [member] Borrowings by name [member] Borrowings by name [member] Change in fair value of investments measured at fair value through profit or loss Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, assets Number of Other Equity Instruments Issued in Share-Based Payment Arrangement Issued (in shares) Number of Other Equity Instruments Issued in Share-Based Payment Arrangement Number of Other Equity Instruments Issued in Share-Based Payment Arrangement Option Expiration Period [Axis] Option Expiration Period [Axis] Option Expiration Period Disclosure of Fair Value Measurement of Assets and Liabilities [Table] Disclosure of Fair Value Measurement of Assets and Liabilities [Table] Disclosure of Fair Value Measurement of Assets and Liabilities [Table] Employee Employee [Member] Employee Schedule of Changes in Fair Value of Financial Assets Disclosure of fair value measurement of assets [text block] Intangible assets other than goodwill Balance Balance Intangible assets other than goodwill Change in fair value of contingent consideration Adjustments For Gains (Losses) On Change In Fair Value For Contingent Liabilities Recognised In Business Combination Adjustments For Gains (Losses) On Change In Fair Value For Contingent Liabilities Recognised In Business Combination United States of America, Dollars United States of America, Dollars Basis of measurement Explanation of measurement bases used in preparing financial statements [text block] Profit (loss) Profit (loss) Profit (loss) Financial assets, measured at amortized cost: Financial assets at amortised cost, category [member] Payroll and Benefits Payroll and Benefits Payroll and Benefits Increase (decrease) through net exchange differences, intangible assets and goodwill Increase (decrease) through net exchange differences, intangible assets and goodwill Common Stock Shares Authorized Value Common Stock Shares Authorized Value Common Stock Shares Authorized Value Subscription, fee percentage, president's list Share Subscription, Fee Percentage, Presidents List Orders Share Subscription, Fee Percentage, Presidents List Orders Basic earnings (loss) per share Diluted earnings (loss) per share Share issuance costs Tax Effect Of Share Issuance Costs Tax Effect Of Share Issuance Costs Pre-acquisition cash advances to Adelia Consideration paid (received) Loss Generation Period [Axis] Loss Generation Period [Axis] Loss Generation Period Equity component of convertible debt Reserve of equity component of convertible instruments [member] Option issuance Adjustments For Option Issuance Adjustments For Option Issuance Disclosure of contingent liabilities in business combination [line items] Disclosure of contingent liabilities in business combination [line items] Exercise price, share options granted Exercise price, share options granted Financial assets Balance at beginning of period Balance at end of period Financial assets Share capital [member] Share capital [member] OPERATING ACTIVITIES Cash flows from (used in) operating activities [abstract] Expected annual volatility, based on comparable companies Expected Volatility, Other Equity Instruments Granted Expected Volatility, Other Equity Instruments Granted Common shares Ordinary shares [member] Net changes in non-cash working capital items: Adjustments For Working Capital [Abstract] Adjustments For Working Capital Income tax recovery Tax expense (income) Tax expense (income) Total Key management personnel compensation Additions Purchases, fair value measurement, assets Accumulated depreciation and amortisation [member] Accumulated depreciation and amortisation [member] Investments Investments [Member] Investments Entity Central Index Key Entity Central Index Key Payments for share issue costs Payments for share issue costs Option Expiration Period Thirty Three Option Expiration Period Thirty Three [Member] Option Expiration Period Thirty Three Option Expiration Period Seventeen Option Expiration Period Seventeen [Member] Option Expiration Period Seventeen Disclosure of non-adjusting events after reporting period [table] Disclosure of non-adjusting events after reporting period [table] Subscription, fee percentage Share Subscription, Fee Percentage Share Subscription, Fee Percentage Option life, share options granted Option life, share options granted Share-based payment arrangements [member] Share-based payment arrangements [member] City Area Code City Area Code Provisions Description of accounting policy for provisions [text block] Financial liabilities, measured at amortized cost: Financial liabilities at amortised cost, category [member] Warrants, percentage of subscriptions Share Subscriptions, Securities Called by Warrants, Percentage of Subscriptions Share Subscriptions, Securities Called by Warrants, Percentage of Subscriptions Milestone Transaction [Domain] Milestone Transaction [Domain] Milestone Transaction [Domain] Number of options, expired (in shares) Number of share options expired in share-based payment arrangement Euro Member Countries, Euro Euro Member Countries, Euro Proceeds from issuing other equity instruments Proceeds from issuing other equity instruments SHAREHOLDERS' EQUITY Equity [abstract] Terminal growth rate Terminal Growth Rate, Measurement Input [Member] Terminal Growth Rate, Measurement Input schedule of subsidiaries and functional currencies [Table] schedule of subsidiaries and functional currencies [Table Text Block] schedule of subsidiaries and functional currencies Sale Of Stock [Domain] Sale Of Stock [Domain] Sale Of Stock [Domain] Current financial assets at fair value through profit or loss [abstract] Current financial assets Rx Hybrid Instrument Rx Hybrid Instrument [Member] Rx Hybrid Instrument FINANCIAL INSTRUMENTS Disclosure of financial instruments [text block] TOTAL ASSETS Assets Financial liabilities, category [member] Financial liabilities, category [member] Weighted average share price, share options granted Weighted average share price, share options granted Items of contingent liabilities [member] Items of contingent liabilities [member] Warrants Warrants [Member] Warrants Outstanding (in CAD per share) Outstanding (in CAD per share) Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement Conversion of stock, shares exchange (in shares) Conversion Of Stock, Shares Converted Conversion Of Stock, Shares Converted Expected forfeiture as percentage Expected Forfeiture As Percentage, Other Equity Instruments Exercised Or Vested Expected Forfeiture As Percentage, Other Equity Instruments Exercised Or Vested Investments [Abstract] Investments [Abstract] Weighted average exercise price, assumed in consolidation (in dollars per share) Weighted Average Exercise Price Of Share Options Assumed In Share Consolidation In Share-Based Payment Arrangement Weighted Average Exercise Price Of Share Options Assumed In Share Consolidation In Share-Based Payment Arrangement Categories of related parties [axis] Categories of related parties [axis] Impairment of long-lived assets Description of accounting policy for impairment of assets [text block] Depreciation Adjustments for depreciation expense INVESTMENTS Disclosure of investment entities [text block] Investment, Type [Domain] Investment, Type [Domain] Investment, Type [Domain] Summary of number and weighted average exercise prices of share options Disclosure of number and weighted average exercise prices of share options [text block] Statement of changes in equity [table] Statement of changes in equity [table]